View in EDS

MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma.

Saved in:
Bibliographic Details
Title: MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma.
Authors: Moreno-Moreno E; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain., Caniego-Casas T; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain; Alcalá University, Faculty of Medicine, Alcalá de Henares, Spain., Ruz-Caracuel I; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain., Carretero-Barrio I; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain., Cabezas-López E; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Gynecologic Oncology, Madrid, Spain., Cortés-Salgado A; Alcalá University, Faculty of Medicine, Alcalá de Henares, Spain; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Medical Oncology, Madrid, Spain., Mendiola M; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain; Hospital La Paz Institute for Health Research (IdiPAZ), Molecular Pathology and Therapeutic Targets Group, Madrid, Spain., Redondo A; Hospital Universitario La Paz, IdiPAZ, School, Universidad Autónoma de Madrid, Department of Medical Oncology, Madrid, Spain., Muriel A; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, Madrid, Spain; Alcalá University, Nursery Department and Physiotherapy, Alcalá de Henares, Spain; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Hardisson D; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain; Hospital Universitario La Paz, Department of Pathology, Madrid, Spain; Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdidPAZ), Madrid, Spain; Universidad Autónoma de Madrid, Faculty of Medicine, Madrid, Spain., Palacios J; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain; Alcalá University, Faculty of Medicine, Alcalá de Henares, Spain., Pérez-Mies B; Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Department of Pathology, Madrid, Spain; Biomedical Research Networking Centre in Cancer (CIBERONC), Madrid, Spain; Alcalá University, Faculty of Medicine, Alcalá de Henares, Spain. Electronic address: bperezm@salud.madrid.org.
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Apr; Vol. 36 (4), pp. 104563. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-1438
DOI:10.1016/j.ijgc.2026.104563